[ 鐧诲綍] [ 鍏嶈垂娉ㄥ唽]
璇曞墏浠櫒缃? title=
浣嶇疆锛欬a href="/">棣栭〉> 浜у搧搴掽/a> > Avibactam free acid
绔嬪嵆鍜ㄨ
鍜ㄨ绫诲瀷锛欬/div>
*濮撳悕锛欬/div>
*鐢佃瘽锛欬/div>
*鍗曚綅锛欬/div>
Email锛欬/div>
*鐣欒█鍐呭锛欬/div>
璇疯缁嗚鏄庢偍鐨勯渶姹傘€
*楠岃瘉鐮侊細
Avibactam free acid
鏈骇鍝佷笉鍚戜釜浜洪攢鍞紝浠呯敤浣滅瀛︾爺绌讹紝涓嶇敤浜庝换浣曚汉浣撳疄楠屽強闈炵鐮旀€ц川鐨勫姩鐗╁疄楠屻€侟/div>
Avibactam free acid鍥剧墖
CAS NO: 1192500-31-4
鍖呰: 5 mg
甯傚満浠耳 7000鍏傸/td>

浜у搧鍚嶇О
NXL-104 free acid
浜у搧浠嬬粛

浜у搧鎻忚堪

Avibactam (NXL-104) free acid is a covalent and reversible inhibitor of non-尾-lactam 尾-lactamase (IC50s: 8 nM and 5 nM for 尾-lactamase TEM-1 and CTX-M-15).

浣撳娲绘€?/h3>
Avibactam inhibits class A and C 尾-lactamases. Avibactam inactivates the most important 尾-lactamases except metallo types and Acinetobacter OXA carbapenemases [2].

浣撳唴娲绘€?/h3>
Avibactam sodium displays a slow return of activity with an off-rate of 0.045卤0.022/min, which converts to a residence time half-life (tt1/2) of 16卤8 min. The measured off-rate for Avibactam suggests that slow deacylation through hydrolysis or reversibility is occurring, and it is in contrast to previously reported extremely long t1/2 values of >1 or >7 d for Avibactam inhibition of TEM-1 [1]. Mice are infected with ca.106 CFU of Pseudomonas aeruginosa intramuscularly into the thigh or intranasally to cause pneumonia and are given 8 different (single) subcutaneous doses of Ceftazidime and Avibactam in various combined concentrations, ranging from 1 to 128 mg/kg of body weight in 2-fold increases. The mean estimated half-life in plasma of Ceftazidime in the terminal phase is 0.28 h (SD, 0.02 h), and that of Avibactam is 0.24 h (SD, 0.04 h). Volumes of distribution are 0.80 liters/kg (SD, 0.14 liters/kg) and 1.18 liters/kg (SD, 0.34 liters/kg), respectively [3].

Cas No.

1192500-31-4

鍒嗗瓙寮廃/h3>
C7H11N3O6S

鍒嗗瓙閲廃/h3>
265.24

鍒悕

NXL-104 free acid

鍌ㄥ瓨鍜屾憾瑙e害

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20掳C for 3 years
In solvent: -80掳C for 2 years
Baidu
map